References
- Elias D, Gilly F, Quenet F, Bereder JM, Sidéris L, Mansvelt B, et al. Pseudomyxoma peritonei: A French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol 2010;36:456–62
- Baratti D, Scivales A, Balestra MR, Ponzi P, DiStasi F, Kusamura S, et al. Cost analysis of the combined procedure of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Surg Oncol 2010;36:463–9
- Sommariva A, Pilati P, Rossi CR. Cytoreductive surgery combined with hyperthermic intra-peritoneal chemotherapy for peritoneal surface malignancies: Current treatment and results. Cancer Treat Rev 2012;38:258–68
- Sugarbaker PH. Surgical responsibilities in the management of peritoneal carcinomatosis. J SurgOncol 2010;101:713–24
- Nissan A, Garofalo A, Esquivel J. Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) for gastric adenocarcinoma: Why haven’t we reached the promised land? J Surg Oncol 2010;102:359–60
- Yatsenko LD. Peculiarities of stage IV metastatic gastric cancer. Oncology (Ukraine) 2007;9:139–44
- Bando E, Yonemura Y, Takeshita Y, Taniguchi K, Yasui T, Yoshimitsu Y, et al. Intraoperative lavage for cytological examination in 1297 patients with gastric carcinoma. Am J Surg 1999;178:256–62
- Yoo CH, Noh SH, Shin DW, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma. Br J Surg 2000;87:236–42
- Macdonald JS. Advances in the management of gastric cancer. New York: CMP Medica, 2006
- Sobin LH, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours, 7th edition. Chichester: Wiley-Blackwell, 2010
- Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-esophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial. Lancet 2010;376:687–97
- Hermans J, Bonenkamp JJ, Boon MC, Bunt AM, Ohyama S, Sasako M, et al. Adjuvant therapy after curative resection for gastric cancer: Meta-analysis of randomized trials. J Clin Oncol 1993;11:1441–7
- Janunger KG, Hafstrom L, Glimelius B. Chemotherapy in gastric cancer: A review and updated meta-analysis. Eur J Surg 2002;168:597–608
- Japanese Gastric Cancer Association. Japanese classification of gastric cancer, 2nd ed. Gastric Cancer 1998;1:10–24
- Sugarbaker PH. Management of peritoneal-surface malignancy: The surgeon’s role. Langenbeck’s Arch Surg 1999;384:576–87
- Cassidy J, Bissett D, Spence R, Payne M. Oxford Handbook of Oncology, 3rd ed. Oxford: Oxford University Press, 2010
- Xu DZ, Zhan YQ, Sun XW, Cao SM, Geng OR. Meta-analysis of intraperitoneal chemotherapy for gastric cancer. World J Gastroenterol 2004;10:2727–30
- Yan TD, Black D, Sugarbaker PH, Zhu J, Yonemura Y, Petrou G, et al. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for respectable gastric cancer. Ann Surg Oncol 2007;14:2702–13
- Mi DH, Li Z, Yang KH, Cao N, Lethaby A, Tian JH, et al. Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: A systematic review and meta-analysis of randomised controlled trials. Int J Hyperthermia 2013;29:156–67
- Sugarbaker PH. Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy. Int J Hypertherm 2007;23:431–42
- Yonemura Y, Fujimura T, Nishimura G, Falla R, Sawa T, Katayama K, et al. Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 1996;119:437–44
- Glehen O, Gilly FN, Arvieux C, Cotte E, Boutitie F, Mansvelt B, et al. Peritoneal carcinomatosis from gastric cancer: A multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 2010;17:2370–7